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James C. Scheirer, PhD, and Alan M. Graham, MD, New Brunswick, NJ
Objectives: With the evolution of endovascular techniques, carotid artery stenting (CAS) has been compared to carotid
endarterectomy (CEA). Several studies have reported inferior results with CAS in the elderly. The objective of this study
was to evaluate national outcomes of CAS and CEA and to compare utilization and outcomes of these procedures in
different age groups.
Methods: We evaluated the 2005 Nationwide Inpatient Sample for hospitalizations with a procedure of CAS or CEA
within 2 days after admission at age 60 years and above. Procedures were analyzed with respect to patient demographics
and associated complications.
Results: A total of 80,498 carotid interventions (73,929 CEA and 6,569 CAS) were identified. The overall incidence of
stroke was 4.16% after CAS and 2.66% after CEA (P < .0001). CAS was more often utilized in octogenarians than in
younger patients (8.55% in 80 vs 7.92% in 60-69 years; P< .0002). Increased age was not associated with greater stroke
rates after CAS or CEA (P .19 and .06, respectively). Octogenarians, compared to younger patients, had greater cardiac,
pulmonary, and renal complications after CEA (3.0% vs 1.9%, 1.9% vs 1.0%, and 1.4% vs 0.54%, respectively; P< .0001).
When adjusted by age, gender, complications, and Elixhauser comorbidities, patients after CAS were 1.6 times as likely
to have a stroke (confidence interval [CI]  1.37-1.78) when compared to CEA. Significant predictors of postoperative
hospital mortality were stroke (odds ratio [OR] 29.0; 95% CI 21.5-39.1), cardiac complications (OR 6.4; 95% CI
 4.4-9.1), pulmonary complications (OR 3.5; 95% CI 2.31-5.19), and renal failure (OR 2.5; 95% CI 1.6-3.8).
With increasing age, overall mortality steadily increased after CAS (from 0.23% to 0.67%; P .0409) but remained stable
after CEA.
Conclusion:Octogenarians did not have a higher risk of stroke after CAS when compared to younger patients. Stroke was
the strongest predictor of hospital mortality. The increased utilization of CAS in the aged, which had significantly higher
stroke rates in all age groups studied, may account for the greater hospital mortality seen after CAS in the elderly. Further
studies focused on the aged are needed to define the best management strategies in the elderly. ( J Vasc Surg 2009;49:
325-30.)Carotid endarterectomy (CEA) has been established as
the gold standard for the management of carotid disease
through large prospective randomized trials.1-3 However,
as technology has evolved there has been the implementa-
tion of carotid artery stenting (CAS) for the management of
carotid artery disease with reported noninferiority4,5 as well
as inferior results when compared to CEA.6 Studies includ-
ing the 30-day lead-in results from the Carotid Revascu-
larization Endarterectomy vs Stent Trial (CREST) and
the 30-day results from the Stent-Supported Percutane-
ous Angioplasty of the Carotid Artery vs Endarterectomy
(SPACE) trial have demonstrated adverse outcomes and
increased stroke rate after CAS in the elderly.4,5,7,8 Pro-
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It has been estimated that the number of persons aged
65 years and above in the United States will more than
double between 2000 and 2030 and that the proportion of
elderly in the total population will increase from 12.4% to
19.6%.10 With the elderly increasing the demand on health
care, the best treatment of carotid disease is an important
health concern for the future. Understanding that single
institutions and trial data may not be generalizable to the
population at large, we evaluated national outcomes of
CAS with our focus on the elderly.
METHODS
Data source. The Nationwide Inpatient Sample (NIS)
for the year of 2005 was used for this study. The NIS is the
largest all-payer hospital database developed as part of the
Healthcare Cost and Utilization Project (HCUP), spon-
sored by the Agency for Health Care Research and Quality
(AHRQ).11 This publicly available database contains data
about approximately 8,000,000 hospital stays from more
than 1,000 hospitals and represents a 20% sample of hospi-
tals in the United States. The NIS sampling and weighting
strategies provide researches with the opportunity to obtain
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Study population. All adult patients aged 60 years
and older who underwent CAS or CEA within 2 days after
elective admission to the hospital were analyzed. We used
the International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) procedure code 00.63
in any of 15 procedure positions in the data to identify
patients with CAS and procedure code 38.12 to select cases
with CEA. Because the NIS database contains information
about the number of days from admission to each proce-
dure performed, we selected only those observations where
CAS or CEA were carried out within 2 days after admission.
This approach, in association with the elective type of
admission, was employed to focus on the cohort of patients
hospitalized primarily for performing the procedure. The
NIS administrative data do not yet have an indicator that
distinguishes between diagnoses presented at admission
and those arising during hospitalization. We identified the
following complications with the appropriate ICD-9-CM
diagnosis codes for the secondary diagnoses: cardiac com-
plications including myocardial infarction (MI) (997.1,
410.00-410.02, 410.10-410.12, 410.20-410.22, 410.30-
410.32, 410.40-410.42, 410.50-410.52, 410.60-410.62,
410.70-410.72, 410.80-410.82, 410.90-410.92), pulmo-
nary (997.3, 518.4, 518.5), and renal (997.5) complica-
tions. Identifying stroke as a complication, we utilized
ICD-9 code 997.02 (postoperative stroke) and other ap-
propriate codes for stroke. The ICD-9 descriptions and the
distribution of stroke each code adds for patients after CAS
and CEA is in Table I. Stroke is considered an acute code
and by selecting elective carotid interventions patients
should not have acute stroke codes in their administrative
discharge data unless they occurred during that hospitaliza-
tion in association with a carotid intervention. To identify
symptomatic patients, we used the following ICD-9-CM
diagnosis codes: 435 (transient cerebral ischemia) and all
subcodes, 437.1 (other generalized ischemic cerebrovascu-
lar disease), 781.4 (transient paralysis of limb), 362.34
(transient arterial occlusion, amaurosis fugax), and 368.12
(transient visual loss). The Elixhauser Index12-14 was em-
Table I. Distribution of study population by ICD-9-CM
ICD-9-CM codes Description o
997.01 Central nervous system complication wit
997.02 Iatrogenic cerebrovascular infarction or h
997.00 Nervous system complication, unspecifie
997.09 Other nervous system complications.
433.11 Occlusion and stenosis of the carotid art
434.01 Cerebral thrombosis with infarction.
434.11 Cerebral embolism with infarction.
434.91 Cerebral artery occlusion, unspecified wi
Total
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinicployed to identify and adjust for comorbidities in the studycohort. NIS data includes 29 AHRQ comorbidity measures
reported by Elixhauser et al.13 To identify these comorbidi-
ties we used the Comorbidity Software developed as part of
the HCUP.15 The performance of the Elixhauser comor-
bidity measures in predicting patient outcomes are well
validated and has been established in the prediction of
in-hospital and 1 year mortality among patients with con-
gestive heart failure (CHF), diabetes, chronic renal failure
(CRF), stroke, and patients undergoing coronary artery
bypass grafting (CABG).14 For the analysis of the age
disparities, we divided all study population into three age
categories: 60-69, 70-79, and 80 years and above.
Statistical analysis. We used SAS 9.1 software (SAS
Institute, Cary, NC) for the analysis of the database and all
statistics. To test the difference between two groups, we
utilized 2 analysis with calculating odds ratio (OR) and
95% confidence interval (CI) for categorical variables, t test
or Wilcoxon rank-sum test for continuous variables (with
normal and non-normal distribution, respectively), and
calculated the z-ratio with P value for the significance of
the difference between two independent proportions. The
Cochran-Armitage trend test was employed to analyze
procedure performance and changes in the postoperative
complications with the patient’s age. We employed multi-
variate logistic regression analysis to compare complica-
tions and mortality in patients after CAS and CEA adjusted
by age, gender, and comorbidities. A P  .05 was consid-
ered significant.
RESULTS
Using the weighting function, 80,498 carotid interven-
tions were identified in hospitalized patients aged 60 years
and older in the United States in 2005: 73,929 CEA
(91.8% of all carotid interventions) and 6569 CAS (8.2%).
Table I displays demographic and clinical characteristics of
the study population.
The major complications after CAS and CEA in various
age groups are shown in Table II. Stroke was the most
common complication after carotid intervention. In our
study group, the overall incidence of stroke was 4.16% after
CAS and 2.66% after CEA (P  .0001), and the same
e codes utilized
s
% of study population
with CAS with CEA
bral hypoxia. 0.06 0.05
rrhage. Postoperative stroke. 2.08 1.03
0.39 0.39
ith cerebral infarction. 0.99 0.84
0.64 0.35
arction.
4.16 2.66
ification; CAS, carotid artery stenting; CEA, carotid endarterectomy.strok
f code
h cere
emo
d.
ery w
th infphenomenon was noted in all age groups (P  .0002).
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age each added to the overall stroke rate. We did not find a
significant positive trend in stroke rate with aging after
either procedure. After adjustment by age, gender, and
comorbidities, patients after CAS were still 1.6 times as
likely to have a stroke (95% CI  1.37-1.78) as patients
after CEA. After CEA, cardiac, pulmonary, and renal com-
plications in the elderly significantly increased with the
advanced age of the patients. Among patients with CAS,
pulmonary and renal complications developed more fre-
quently in those who were older.
A significant increase in the utilization of CAS was
found with aging. Patients aged 60-69 years underwent
CAS for 7.92% of all interventions. In patients aged 70-79
years CAS was utilized more often (8.15%). The greatest
proportion of CAS was found in octogenarians 8.55%. On
the contrary, a proportion of CEA steadily decreased with
the age of patients from 92.08% in patients aged 60-69
years to 91.85% at 70-79 years and to 91.45% in octoge-
narians; P  .0277 utilizing the Cochran-Armitage trend-
test.
Fifty-eight percent of study patients were men and their
Table II. Demographic and clinical characteristics of
study patients
Characteristic CAS CEA P value
Number of patients 6569 (8.2%) 73,929 (91.8%) .0002
Age, year
(mean  SD) 73.4  7.53 73.2  7.33 .3664
Gender:
Men 4041 (61.5%) 42,382 (57.3%) .0002
Women 2528 (38.5%) 31,537 (42.7%) .0002
Missing 0 11
Complications:
Stroke 273 (4.16%) 1963 (2.66%) .0002
Cardiac 139 (2.12%) 1728 (2.34%) .2535
Pulmonary 25 (0.38%) 1016 (1.37%) .0002
Renal 30 (0.46%) 661 (0.89%) .0002
Symptomatic patients 189 (2.88%) 2048 (2.77%) .6136
Died 25 (0.38%) 189 (0.26%) .0596
CAS, Carotid artery stenting; CEA, carotid endarterectomy; SD, standard
deviation.
Table III. Postoperative complications (%) in different
age groups
Complications Procedures
Age groups, years
P for trend60-69 70-79 80
Stroke CAS 4.16 4.69 3.13 .1942
CEA 2.51 2.70 2.79 .0649
Cardiac CAS 1.42 2.93 1.52 .4862
CEA 1.91 2.35 2.99 .0001
Pulmonary CAS 0.47 0.17 0.68 .0258
CEA 1.02 1.37 1.94 .0001
Renal CAS 0 0.68 0.70 .0006
CEA 0.54 0.92 1.41 .0001
CAS, Carotid artery stenting; CEA, carotid endarterectomy.proportion among CAS patients (61.5%) was greater thanamong patients undergoing CEA (57.3%; P  .0002). A
similar distribution was found in all the age groups. Overall,
men were 1.2 times as likely as women to have CAS.
Hospital charges for CAS were found to be significantly
greater when compared to CEA ($29,171 vs $20,052, P
.001).
Overall mortality among elderly patients after CAS
(0.38%) tended to be greater than in patients after CEA
(0.26%; P .056). In univariate analysis of the whole study
population, men were 1.5 times as likely to die as women
(95% CI  1.15-2.04). When adjusting by age, gender,
type of procedure, comorbidities, and complications in
multivariate analysis, the difference remained significant
(OR  2.03; 95% CI  1.028-4.027). It was also found
that with increasing age, mortality steadily increased after
CAS (from 0.23% to 0.67%; P  .0409) utilizing the
Cochran-Armitage trend-test, but this trend was not noted
after CEA (0.22% to 0.29%; P  .86). There were no
significant differences in mortality rates between patients
with CAS and CEA in age groups 60-69 and 70-79 years.
However, octogenarians after CAS procedure were 2.3
times as likely to die as those after CEA (95% CI 
1.16-4.59).
In univariate analysis, there were no significant differ-
ences in stroke rates between men and women both after
CAS and CEA. In the multivariate analysis, when adjusted
by age, gender, comorbidities, and type of procedure (CAS
or CEA), we did not find gender differences in stroke
either. In both men and women the rate of stroke after CAS
was greater than after CEA.
To adjust for confounding variables, multivariate logis-
tic regression analysis was performed with postoperative
hospital mortality or stroke as an outcome (Tables IV and V)
and age, gender, procedure (CAS or CEA), postoperative
complications and Elixhauser comorbidities as the indepen-
dent variables. The most significant predictor of postoper-
ative hospital mortality was stroke (OR  29.0; 95% CI 
21.54-39.08), followed by cardiac complications (OR 
6.4; 95% CI 4.44-9.09), pulmonary complications (OR
3.5; 95% CI  2.31-5.19), and renal failure (OR  2.5;
95% CI  1.6-3.8). Women were found to be less likely to
die compared to men (OR  0.48; 95% CI  0.35-0.66).
After adjusting for comorbidities, patients after CAS were
more likely to have a postoperative stroke after CAS (OR
Table IV. Risk factors for postoperative mortality
Covariates Adjusted OR* 95% CI
Stroke 29.0 21.5-39.1
Cardiac complication 6.4 4.4-9.1
Pulmonary complication 3.5 2.3-5.2
Female 0.5 0.4-0.7
Renal failure 2.5 1.6-3.8
OR, Odd ratio; CI, confidence interval.
*Model adjusted using Elixhauser comorbidities, age, gender, and compli-
cations.1.6; 95% CI  1.4-1.8), as were patients with renal failure
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4.2; 95% CI 2.4-7.5), and fluid and electrolyte disorders
(OR  1.9; 95% CI  1.6-2.3).
We compared length of hospital stay (LOS) and hospi-
tal cost for patients with CAS and CEA. Mean LOS with
standard deviation (SD) in patients with CAS was 1.8 
2.33 days whereas in patients with CEA it was 2.1  2.69
days. In contrast to these findings, hospital cost for patients
with CAS was $11,717  6,242 while for patients with
CEA it was $7,926 7,320; we analyzed the differences in
LOS and cost between patients with CAS and CEA with
non-parametric Wilcoxon rank sum test and these differ-
ences were found to be significant (P  .0001 for both).
DISCUSSION
As the proportion of older patients steadily increases,
the best management of carotid disease in this population
will become more germane. It is expected that the number
of elderly with cardiovascular disease will produce a signif-
icant economic burden on the medical system.16 It has also
been shown that as the population ages and requires more
health care, a significant part of this is in surgical services.17
There is a generalized perception that a minimally invasive
intervention such as CAS may be better tolerated over a
surgical, open CEA, but the debate has continued to what
constitutes the safest management for this group of pa-
tients. Considering the potential rise in utilization of CAS
and the increased cost of CAS18 there remains controversy
delineating the best management of carotid disease in the
aged.
The NIS data for 2005, contrary to previously pub-
lished trial and registry results, demonstrates similar stroke
rates after CAS in all age groups examined. CAS was found
to have a significantly higher risk of stroke overall. Previ-
ously published results showing higher stroke rates in oc-
togenarians include the CREST 30-day lead-in phase
study,7 the 30-day results of the SPACE trial,4 and the
CAPTURE registry.4,19 Data from the lead-in phase of the
CREST trial evaluated 30-day stroke and death among 749
patients who had undergone carotid angioplasty and stent-
ing for symptomatic carotid stenosis and found that octo-
genarians had an increased rate of 12.1%, which was signif-
icantly higher than the rates of patients aged 70-79 (5.3%),
60-69 (1.3%), and less than 60 years (1.7%).7
Multiple smaller series have shown no increased com-
Table V. Risk factors for postoperative stroke
Covariates Adjusted OR* 95% CI
CAS 1.6 1.4-1.8
Renal failure 2.0 1.6-2.4
Metastatic cancer 4.2 2.4-7.5
Fluid & electrolyte disorders 1.9 1.6-2.3
OR, Odd ratio; CI, confidence interval; CAS, carotid artery stenting.
*Model adjusted using Elixhauser comorbidities, age, gender, and compli-
cations.plications in the use of CAS in the elderly. Shawl et al20reported no difference in the 30-day stroke rate between
octogenarians and younger patients in a cohort of 170
consecutive patients. Ahmadi et al21 as well found no
significant difference in neurological complications at 30
days between patients above the age of 75 years and pa-
tients below age 75, and this series concluded that elective
carotid stenting can be performed safely in older patients
and age was not an independent risk factor for poor inferior
outcomes after CAS. Finally, Kadkhodayan et al22 demon-
strated no significant difference after CAS in the 30-day rate
of stroke, transient ischemic attack (TIA), MI, or death
between the elderly and younger patients.
We have demonstrated using national data that stroke
rates are not greater in the elderly after CAS or CEA. We
have demonstrated that CAS has a higher overall stroke rate
compared to CEA and that CAS is more often utilized in
the elderly. Overall, this creates inferior outcomes in the
aged. Other studies have also demonstrated increased uti-
lization of CAS in the elderly. The Arbeitsgemeinschaft
Leitende Kardiologische Krankenhausarzte (ALKK) Ca-
rotid Artery Stent Registry studied 2,780 CAS procedures
and noted a significant increase in the proportion of octo-
genarians between 1996 (5.9%) and 2005 (13.7%) under-
going CAS.23 The higher percentage of patients over age 80
receiving CAS demonstrated from this study may represent
more liberal use of the procedure in older patients, reluctance
to perform CEA in the elderly, more stringent criteria for
CEA, or provider bias based on perceived lower risk of CAS.
Of greatest importance is that these data demonstrate
that the overall stroke rate is significantly greater after CAS
(4.16%) when compared to CEA (2.66%). Previous studies
have reported increased stroke rate after CAS, including the
Endarterectomy vs Angioplasty in Patients with Symptom-
atic Severe Carotid Stenosis (EVA-3S) investigators.6 The
EVA-3S investigators reported a 30-day incidence of stroke
or death among patients who underwent stenting (9.6%),
as compared with those who underwent surgery (3.9%).
Inferior outcomes for CAS have also been reported by
other authors using national discharge data.24
The dissemination of new technology into the popula-
tion at large may lead to different outcomes than reported
from trial and registry data. Explanations for these differ-
ences may include variations in practice, experience of the
operator, patient selection, the learning curve utilizing
CAS, and the lack of regimented protocols mandated by
studies. Mas et al6 referred to the “learning curve” for carotid
stenting as a reason for the inferior results associated with CAS
in this study. It has been established that the risk associated
with carotid endarterectomy varies among surgeons and CAS
likely has similar risks associated with the operator.
With regard to utilization for CAS, we found hospital
charges for CAS to be significantly greater when compared
to CEA, even though the LOS was found to be greater for
CEA. Others have reported procedural costs of CAS are
higher than those of CEA, primarily due to material costs
and that cost-effectiveness and utilization of CAS primarily
depends on major stroke rates which are greater after
CAS.25 As well, Kilaru et al26 demonstrated CEA as cost
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with CAS and the high cost of stents. Therefore, from a
global utilization perspective for treatment of the elderly,
CAS may demonstrate inferior cost-effectiveness.
Overall mortality among elderly patients after CAS was
found to be greater than in patients after CEA. To adjust
for comorbidities we utilized the validated Elixhauser13
method for administrative data and mortality still remained
higher in the elderly. Explanations for inferior outcomes
after CAS for octogenarians is primarily due to the in-
creased stroke rates associated with CAS. Stroke was found
to be the greatest predictor of mortality and carried a 29
times greater risk of death. Octogenarians were significantly
more likely to receive CAS than other age groups and this
may account for the increased mortality in the CAS group.
As well, comorbidities including cardiac, pulmonary, and
renal complications were associated with inferior outcomes
after CAS. Renal failure and cancer were also associated
with stroke in all patients. Men were found more likely to
have postoperative mortality in the entire cohort when
including CAS and CEA. These results are similar to other
population-based studies of CEA using Medicare data
showing higher mortality for men overall.27
One of the major limitations of this study is the coding
used for the diagnosis of stroke. The NIS is an administra-
tive discharge dataset based on billing. The data contained
in the NIS and other discharge datasets are limited by the
coding schemes created by AHRQ and ICD-9 codes. It is
possible that the definition of stroke and the way it is coded
within the dataset may vary between institutions and hos-
pital coders. Previous authors have reported extremely low
stroke rates (0.88%) in the nation at large for CEA.24 The
stroke rate calculated by McPhee et al24 utilized only the
iatrogenic stroke code (997.02) which we believe to be an
underutilized code based on the bias of the hospital coders.
For this reason we expanded the stroke codes utilized with
the rationale that stroke is an acute code and by selecting
elective carotid intervention patients were unlikely to have
acute stroke codes in their administrative discharge data
unless they occurred during that hospitalization in associa-
tion with a carotid intervention.
Other limitations are that the NIS database does not
include patients in military hospitals or VA medical centers.
The potential for inclusion bias based on limited coding
schemes for the many clinical entities cannot be entirely
excluded as well as confounding by indication of the pro-
cedures. Classification as elective vs non-elective was based
on the HCUP variable for admission type. We acknowledge
that there is a trade-off in using administrative data on thou-
sands of patients and the use of smaller cohorts with more
refined clinical information. While both types of studies have
drawbacks and strengths, we feel that administrative data
provides valuable population-based information on carotid
procedure outcomes. Of course the CEA group of patients
suffers these same limitations, thus supporting the differences
between the CAS and the CEA groups.
In conclusion, this study suggests that the paradigm of
utilizing CAS for management of carotid disease in the elderlymay not offer improved outcomes and likely increases re-
source utilization. Octogenarians were significantly more
likely to have received CAS than younger patients. The great-
est predictor of mortality was found to be stroke and the
highest stroke rates were associated with CAS. Due to in-
creased utilization and poorer outcomes, mortality after CAS
was found to be greater in octogenarians. Further prospective
analysis with emphasis on the aged is needed to determine the
best management as the percentage of elderly in the US
population steadily grows over time.
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Dr Michael Stoner (Greenville, NC). I enjoyed the presen-
tation and would first like to thank the authors for the ability to
review the study prior to the meeting. This continues the trend of
the Nationwide Inpatient Sample (NIS) data that we’ve seen at the
meeting in the last couple days, with a similar spin coming out over
and over again. These presentations are consistently showing a
higher stroke rate for carotid artery stenting (CAS). The purpose of
this paper is to show the influence of age on carotid revasculariza-
tion outcomes, both carotid endarterectomy (CEA) and CAS. I
have a few questions for the authors regarding the study.
First of all, I realize that the NIS does not have temporal data
with respect to the codes used to select for stroke, so the authors
selected procedures within 48 hours of admission. Therefore, they
attempted to not select out those patients who are in-house and
already have a stroke. I’d like the authors to expand on this. Were
most of these procedures done within 24 hours? In other words,
can you tighten up the data a little bit to 24 hours or less, and be
sure that you’re really looking at elective data.
Secondly, your note that the mortality rate was higher in
octogenarians. I was wondering if the NIS data will help us answer
exactly why that is. Do you note more hemorrhagic strokes in the
patients greater than 80 years of age who have a neurological
complication from CAS or CEA?
And lastly, how do these data impact your practice? If we used
a traditional surgical metric of stroke-death, carotid artery stenting
is the loser at all points in your study. What do the authors advocate
with respect to the use of CAS in the elderly?
Dr Vogel. Thank you for your questions. First, we decided to
limit the study cohort to focus on elective CAS procedures. We chose
to evaluate surgeries performed within 48-hours of admission to
attempt to include only elective procedures. However, the majority of
the procedures were performed within the first 24-hour period.
Regarding the second question, the reality is the stroke codes
contained in administrative data are a significant source of confu-
sion based on the limitations of the data. The code most commonly
evaluated in administrative studies is the code for “iatrogenic
stroke”. This is likely under-coded, based on the ability of the
coders at each institution to identify iatrogenic vs all other strokes,
and is an inherent limitation of the dataset. Administrative data isunder-coded by hospitals and we have started a validation study to
further analyze this. For this reason, we have included other codes
for stroke. Stroke is considered an acute diagnosis and by limiting
the cohort as we have to elective procedures we feel our data
represents a more accurate description of stroke after CAS inter-
ventions than other studies using the same NIS dataset. I believe
our study demonstrates that octogenarians do not have a higher
stroke rate after CAS than other patients, but that CAS has a higher
stroke rate than CEA overall. Stroke was the strongest predictor of
mortality, CAS was more often utilized in the elderly, and CAS
carries a higher stroke rate than CEA. This, we believe, accounts
for the higher mortality seen in the elderly.
Finally, regarding your question describing how this data will
impact my practice. We have found CAS to be inferior to CEA
using the NIS data. I believe the use of CAS should be based on the
individual patient with the knowledge that it has a higher stroke
rate than CEA in retrospective administrative data. The choice of
CEA vs CAS must be tempered with patient comorbidities to make
an appropriate decision for each individual patient and this is how
we have modified our practice. Prospective studies, such as the
CREST trial, are needed to answer this question appropriately.
Dr Martin Back (Tampa, Fla). Hospital’s code diagnoses for
patients to maximize reimbursement so the more comorbidities
they document from a chart, the greater the potential revenue.
How accurate do you think these diagnoses are for a given patient?
Your analysis for prognostic variables related to intervention tech-
nique is dependent on that accuracy to give meaningful results.
DrVogel. Yes, the NIS is administrative data based on billing. It
is retrospective data. The code for stroke should not be contained in
the data unless the patient had a stroke at that hospitalization, as it is
considered an acute diagnosis and we limited the cohort to elective
CAS procedures. The reason that the fluid and electrolyte were noted
is that it is one of the 29 Elixhauser comorbidity used in evaluating
administrative data. The Elixhauser comorbidities are a validated tool
for adjusting for comorbidities in administrative data.
Prospective trials are needed to obtain the final answer regard-
ing CAS, and results from these studies using administrative data
are retrospective and should be considered hypothesis generating
as well as reflective of large populations.
